The potential role of CD9 in metastasis was indicated in a different study, describing increased expression of CD9 in breast cancer bone metastasis compared to primary tumors, where CD9 antibody treatment in vivo moderately inhibited the progression of bone lesions (73). Here, CD9 is linked to breast carcinoma.